Active, Not Recruiting
CBM588 in Combination With Nivolumab and Cabozantinib for the Treatment of Advanced or Metastatic Kidney Cancer
NCT05122546
- Conditions
- Adenocarcinoma, Advanced Clear Cell Renal Cell Carcinoma, Advanced Papillary Renal Cell Carcinoma, +26 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States